Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) need to consider for profitability analysis, in latest session share price swings at $6.09 with percentage change of 2.87%. The returns on assets was -146.30% that gives an idea about how efficient management is at using its assets to generate earnings.
The firm attains analyst recommendation of 1.80 on scale of 1-5 with week’s performance of 28.48%. The firm current ratio calculated as 4.70, this value is acceptable if it lies in 1.3% to 3%. But its varies industry to industry. To strengthen these views, active industry firm has Quick Ratio of 4.70, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 6.29, sometimes its remain same with long term debt to equity ratio.
Arbutus Biopharma Corporation (NASDAQ:ABUS) also making a luring appeal, share price swings at $2.45 with percentage change of remains unchanged in most recent trading session. Moving toward returns ratio, ABUS has returns on investment of -15.90% which indicates firm’s investment efficiency or to compare the efficiency of a number of different investments.
While returns on assets calculated as -27.70% hat gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of -35.30%, which is measuring a corporation’s profitability by revealing how much profit generates by ABUS with the shareholders’ money. The firm attains analyst recommendation of 2.00 on scale of 1-5 with week’s performance of -3.92%.
Moving toward ratio analysis, it has current ratio of 18.10 and quick ratio was calculated as 18.10. The debt to equity ratio appeared as 0.00 for seeing its liquidity position. The firm attains analyst recommendation of 2.00 out of 1-5 scale with week’s performance of -3.92%.